Boston Scientific Corp (BSX)
89.86
+0.91
(+1.02%)
USD |
NYSE |
Dec 23, 16:00
89.99
+0.13
(+0.14%)
Pre-Market: 20:00
Boston Scientific Cash from Investing (Quarterly): -1.427B for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Baxter International Inc | -164.00M |
| Haemonetics Corp | -23.37M |
| ResMed Inc | 2.146M |
| Globus Medical Inc | -14.97M |
| Abbott Laboratories | -594.00M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 1.002B |
| Cash from Financing (Quarterly) | 7.00M |
| Free Cash Flow | 1.892B |
| Free Cash Flow Per Share (Quarterly) | 0.4693 |
| Free Cash Flow to Equity (Quarterly) | 384.00M |
| Free Cash Flow to Firm (Quarterly) | 753.38M |
| Free Cash Flow Yield | 1.42% |